Bristol-Myers Squibb
BMY
#190
Rank
HK$823.28 B
Marketcap
HK$404.42
Share price
1.94%
Change (1 day)
-7.84%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2025 (TTM): HK$374.37 Billion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is HK$373.93 Billion. In 2024 the company made a revenue of HK$374.97 Billion an increase over the revenue in the year 2023 that were of HK$351.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$374.37 B-0.16%
2024 HK$374.97 B6.68%
2023 HK$351.49 B-2.54%
2022 HK$360.65 B-0.29%
2021 HK$361.68 B9.73%
2020 HK$329.60 B61.87%
2019 HK$203.61 B15.25%
2018 HK$176.67 B8.84%
2017 HK$162.32 B7.75%
2016 HK$150.64 B17.37%
2015 HK$128.35 B4.21%
2014 HK$123.16 B-3.06%
2013 HK$127.05 B-6.98%
2012 HK$136.58 B-17.22%
2011 HK$165.00 B8.82%
2010 HK$151.62 B17.12%
2009 HK$129.46 B-18.66%
2008 HK$159.16 B11.65%
2007 HK$142.55 B2.32%
2006 HK$139.32 B-6.44%
2005 HK$148.91 B9.1%
2004 HK$136.50 B-16.23%
2003 HK$162.95 B15.32%
2002 HK$141.30 B-5.52%
2001 HK$149.55 B0.54%
2000 HK$148.75 B-1.16%
1999 HK$150.49 B6.24%
1998 HK$141.65 B9.45%
1997 HK$129.42 B11.07%
1996 HK$116.52 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
HK$488.77 B 30.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$500.05 B 33.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$462.56 B 23.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$438.83 B 17.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$369.96 B-1.06%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
HK$452.50 B 21.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$717.35 B 91.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$464.31 B 24.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$280.02 B-25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$78.36 B-79.04%๐Ÿ‡บ๐Ÿ‡ธ USA